Expression of human cathelicidin peptide LL‐37 in inflammatory bowel disease

Cathelicidin peptide LL‐37 plays an important role in the early host response against invading pathogens via its broad‐spectrum anti‐microbial activity. In this study, we investigated LL‐37 expression in the inflamed mucosa of inflammatory bowel disease (IBD) patients. Furthermore, the regulatory me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Exp Immunol
Autores principales: Kusaka, S., Nishida, A., Takahashi, K., Bamba, S., Yasui, H., Kawahara, M., Inatomi, O., Sugimoto, M., Andoh, A.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721246/
https://ncbi.nlm.nih.gov/pubmed/28872665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13047
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares